Industry Growth Insights published a new data on “Liquid Biopsy IVD Market”. The research report is titled “Liquid Biopsy IVD Market research by Types (Circulating Tumor Cells, Circulating Tumor DNA, Extracellular Vesicles, Others), By Applications (Blood Sample Based, Urine Sample Based, Other Bio Fluids Based), By Players/Companies Bio-Rad, Roche, Biocartis, Qiagen, Guardant Health, MDxHealth, OME Care, NeoGenomics Laboraories, Sysmex Inostics, Menarini Silicon Biosystems, Adaptive Biotechnologies, Biocept, Angle plc”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Liquid Biopsy IVD Market Research Report
By Type
Circulating Tumor Cells, Circulating Tumor DNA, Extracellular Vesicles, Others
By Application
Blood Sample Based, Urine Sample Based, Other Bio Fluids Based
By Companies
Bio-Rad, Roche, Biocartis, Qiagen, Guardant Health, MDxHealth, OME Care, NeoGenomics Laboraories, Sysmex Inostics, Menarini Silicon Biosystems, Adaptive Biotechnologies, Biocept, Angle plc
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
224
Number of Tables & Figures
157
Customization Available
Yes, the report can be customized as per your need.
Global Liquid Biopsy IVD Market Report Segments:
The global Liquid Biopsy IVD market is segmented on the basis of:
Types
Circulating Tumor Cells, Circulating Tumor DNA, Extracellular Vesicles, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Blood Sample Based, Urine Sample Based, Other Bio Fluids Based
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bio-Rad
- Roche
- Biocartis
- Qiagen
- Guardant Health
- MDxHealth
- OME Care
- NeoGenomics Laboraories
- Sysmex Inostics
- Menarini Silicon Biosystems
- Adaptive Biotechnologies
- Biocept
- Angle plc
Highlights of The Liquid Biopsy IVD Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Circulating Tumor Cells
- Circulating Tumor DNA
- Extracellular Vesicles
- Others
- By Application:
- Blood Sample Based
- Urine Sample Based
- Other Bio Fluids Based
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Liquid Biopsy IVD Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Liquid biopsy IVD is a new technology that uses a small needle to collect cells from the blood for analysis. This allows doctors to see how well the patient's immune system is working and whether they are at risk for certain diseases.
Some of the key players operating in the liquid biopsy ivd market are Bio-Rad, Roche, Biocartis, Qiagen, Guardant Health, MDxHealth, OME Care, NeoGenomics Laboraories, Sysmex Inostics, Menarini Silicon Biosystems, Adaptive Biotechnologies, Biocept, Angle plc.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Liquid Biopsy IVD Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Liquid Biopsy IVD Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Liquid Biopsy IVD Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Liquid Biopsy IVD Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Liquid Biopsy IVD Market Size & Forecast, 2020-2028 4.5.1 Liquid Biopsy IVD Market Size and Y-o-Y Growth 4.5.2 Liquid Biopsy IVD Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Circulating Tumor Cells
5.2.2 Circulating Tumor DNA
5.2.3 Extracellular Vesicles
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Blood Sample Based
6.2.2 Urine Sample Based
6.2.3 Other Bio Fluids Based
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Liquid Biopsy IVD Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Liquid Biopsy IVD Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Circulating Tumor Cells
9.6.2 Circulating Tumor DNA
9.6.3 Extracellular Vesicles
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Blood Sample Based
9.10.2 Urine Sample Based
9.10.3 Other Bio Fluids Based
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Circulating Tumor Cells
10.6.2 Circulating Tumor DNA
10.6.3 Extracellular Vesicles
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Blood Sample Based
10.10.2 Urine Sample Based
10.10.3 Other Bio Fluids Based
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Circulating Tumor Cells
11.6.2 Circulating Tumor DNA
11.6.3 Extracellular Vesicles
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Blood Sample Based
11.10.2 Urine Sample Based
11.10.3 Other Bio Fluids Based
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Circulating Tumor Cells
12.6.2 Circulating Tumor DNA
12.6.3 Extracellular Vesicles
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Blood Sample Based
12.10.2 Urine Sample Based
12.10.3 Other Bio Fluids Based
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Circulating Tumor Cells
13.6.2 Circulating Tumor DNA
13.6.3 Extracellular Vesicles
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Blood Sample Based
13.10.2 Urine Sample Based
13.10.3 Other Bio Fluids Based
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Liquid Biopsy IVD Market: Competitive Dashboard
14.2 Global Liquid Biopsy IVD Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Bio-Rad
14.3.2 Roche
14.3.3 Biocartis
14.3.4 Qiagen
14.3.5 Guardant Health
14.3.6 MDxHealth
14.3.7 OME Care
14.3.8 NeoGenomics Laboraories
14.3.9 Sysmex Inostics
14.3.10 Menarini Silicon Biosystems
14.3.11 Adaptive Biotechnologies
14.3.12 Biocept
14.3.13 Angle plc